Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly: Jardiance Reduces Risk Of Cardiovascular Death In Type 2 Diabetes And PAD
Lilly: Jardiance Reduces Risk Of Cardiovascular Death In Type 2 Diabetes And PAD
Lilly: Jardiance Reduces Risk Of Cardiovascular Death In Type 2 Diabetes And PAD
Submitted by
admin
on November 16, 2017 - 9:36am
Source:
NASDAQ.com
News Tags:
Jardiance
Eli Lilly
type 2 diabetes
PAD
Headline:
Lilly: Jardiance Reduces Risk Of Cardiovascular Death In Type 2 Diabetes And PAD
Do Not Allow Advertisers to Use My Personal information
